Skip to content
IPC_HH_2025_L6A3551

Agenda and Speakers

Agenda

November 13–15, 2026 | Galveston Island Convention Center (GICC)

  • Friday, November 13
  • Saturday, November 14
  • Sunday, November 15

8:30 AM

GICC Level 1: Side entrance closest to the Hilton

Registration opens

8:30–10:00 AM

GICC Level 2: Grand Ballroom Foyer

Refreshments available

10:15–10:30 AM

GICC Level 2: Grand Ballroom

Welcome by ISGD & UTMB Leadership

Tobias B. Huber; Jochen Reiser

10:30–10:40 AM

GICC Level 2: Grand Ballroom

Texas Welcome

TBD

10:40–11:10 AM

GICC Level 2: Grand Ballroom

Keynote Address: Faster Science: How AI is Rewriting the Pace of Clinical Trials

Kedar Mate

Theme 1

Sponsored by Walden Biosciences

Gaps in Glomerular Disease Clinical Trials: Where Are We Today?

11:15–11:25 AM

GICC Level 2: Grand Ballroom

Introduction

Shikha Wadhwani

11:30 AM–12:15 PM

GICC Level 2: Grand Ballroom

GD Trials Today: Updates from 2025 & 2026 Meetings

Jonathan Barratt; Brad Rovin; Marina Vivarelli

Moderator: Liz Lightstone

12:15–12:30 PM

GICC Level 2: Grand Ballroom

Q&A/Discussion

12:30–1:30 PM

GICC Level 1: West Foyer

Lunch

Theme 2

Past Lessons and Future Vision (Part A)

1:30–1:35 PM

GICC Level 2: Grand Ballroom

Introduction

Kirk Campbell

1:35–2:20 PM

GICC Level 2: Grand Ballroom

From the Rearview Mirror to the Road Ahead for GD Trials

Hiddo Heerspink; Vlado Perkovic; Katherine Tuttle

Moderator: Kirk Campbell

2:25–3:00 PM

GICC Level 2: Grand Ballroom

Lessons Learned in GD Trials: LN, IgAN, C3G, MN

Ana Malvar; Patrick Nachman; Carla Nester; Heather Reich

Moderators: Daniel Gale; Marina Vivarelli

3:00–3:20 PM

GICC Level 2: Grand Ballroom

Q&A/Discussion

3:20–3:50 PM

GICC Level 2: Grand Ballroom Foyer

Coffee/Afternoon Snack

Theme 3

Emerging Biomarkers & Treatment Targets in GD Clinical Trials

3:50–3:55 PM

GICC Level 2: Grand Ballroom

Introduction

Alessia Fornoni

4:00–4:08 PM

GICC Level 2: Grand Ballroom

Biomarkers as Potential Endpoints that Reflect How A Patient Feels, Functions and Survives

Laura Mariani

Moderators: Alessia Fornoni; Laura Barisoni

4:08–4:16 PM

GICC Level 2: Grand Ballroom

A Biomarker Today?… an Endpoint Tomorrow? Anti-nephrin Autoantibodies

Nicola Tomas

4:16–4:24 PM

GICC Level 2: Grand Ballroom

Neutralizing suPAR in Glomerular Disease: From Pathogenic Mechanism to a Therapeutic Phase 2 Trial

Alexander Duncan

4:24–4:32 PM

GICC Level 2: Grand Ballroom

Targeting Innate Immune Pathways in Glomerular Disease: Current Clinical Trials and Emerging Therapies

Timothy Niewold

4:32–4:40 PM

GICC Level 2: Grand Ballroom

Incorporating Gene Delivery to the Podocyte in GD Trials

Alice Brown

4:40–4:50 PM

GICC Level 2: Grand Ballroom

The Future is Here: Cellular Therapy and Bispecific Antibodies for GD

Jonathan Hogan

4:50–5:15 PM

GICC Level 2: Grand Ballroom

Q&A/Discussion

5:15–6:00 PM

GICC Level 2: Grand Ballroom

ROUNDTABLE: Voice of VCs: Translating Science into Therapeutics

Sahir Ali; Mohsin Khan; Michael Torres

Moderator: Vineet Gupta

6:30–7:30 PM

San Luis Resort: Pool Deck

Networking Reception

7:30–9:30 PM

San Luis Resort: Grand Ballroom

Participant Dinner

7:00–8:25 AM

GICC Level 1: West Foyer

Breakfast

Theme 2

Past Lessons and Future Vision (Part B)

8:30–8:35 AM

GICC Level 2: Grand Ballroom

Day 2 Welcome

Shikha Wadhwani

8:35–8:40 AM

GICC Level 2: Grand Ballroom

Introduction

Meg Jardine

8:40–8:55 AM

GICC Level 2: Grand Ballroom

Integrating Mechanistic Biopsies into GD Trials

Matthias Kretzler

Moderators: Meg Jardine; Rafael Kramann

8:55–9:10 AM

GICC Level 2: Grand Ballroom

Leveraging Risk Prediction Tools for Stratification at Randomization

Sean Barbour

9:10–9:25 AM

GICC Level 2: Grand Ballroom

Platform Trials in GD

Suceena Alexander

9:25–9:40 AM

GICC Level 2: Grand Ballroom

Sequential Design and Treatment Combinations for GD Trials

Hiddo Heerspink

9:40–9:50 AM

GICC Level 2: Grand Ballroom

Q&A/Discussion

9:50–10:05 AM

GICC Level 2: Grand Ballroom

Addressing Unmet Needs in Peds Trials: Extrapolation and the SGLT2i Success Story

Louise Oni

Moderator: Myda Khalid

10:05–10:20 AM

GICC Level 2: Grand Ballroom

Addressing Unmet Needs in Post-Transplant Recurrent GD Trials

Priya Verghese

10:20–10:35 AM

GICC Level 2: Grand Ballroom

Q&A/Discussion

10:35–11:00 AM

GICC Level 2: Grand Ballroom Foyer

Coffee/Morning Snack

Theme 4

Regulatory Advances

11:00–11:05 AM

GICC Level 2: Grand Ballroom

Introduction

Barbara Gillespie

11:10–11:40 AM

GICC Level 2: Grand Ballroom

ROUNDTABLE: Voice of the FDA: What Keeps Us Up At Night?

CDER FDA nephrologists: Nadia Chaudhri; Austin Hu; Rekha Kambhampati; Kirtida Mistry; Aliza Thompson

Former CBER nephrologist: Anam Tariq

Moderators: Brendon Neuen; Brad Rovin

CDER: Center of Drug Evaluation and Research. CBER: Center for Biologics Evaluation and Research.

11:40 AM–12:00 PM

GICC Level 2: Grand Ballroom

Q&A/Discussion

12:00–12:30 PM

GICC Level 2: Grand Ballroom

Going Back In Time: Should the TESTING Trial Proceed? Casting the Last Vote of the DSMB

Adeera Levin; Vlado Perkovic

12:30–12:40 PM

GICC Level 2: Grand Ballroom

Q&A/Discussion

12:40–1:40 PM

GICC Level 1: West Foyer

Lunch

1:40–2:15 PM

GICC Level 2: Grand Ballroom

Still Tried and True Endpoints? eGFR, Albuminuria, Proteinuria

Tom Greene; Hiddo Heerspink; Lesley Inker

Moderators: Alex Mercer; Abigail Smith

2:20–2:30 PM

GICC Level 2: Grand Ballroom

Hierarchical Composite Endpoints, from Cardiology trials…to GD trials?!

Lesley Inker

2:30–2:40 PM

GICC Level 2: Grand Ballroom

Clinical Outcomes Assessment as Endpoints: PREPARE-NS

Eloise Salmon

2:40–3:10 PM

GICC Level 2: Grand Ballroom

International GD Trialists’ Response & Q&A

Suceena Alexander; Daniel Gale; Ana Malvar; Jule Pinter; Heather Reich

Moderator: Jonathan Barratt

3:10–3:30 PM

GICC Level 2: Grand Ballroom Foyer

Coffee/Afternoon Snack

3:30–4:15 PM

GICC Level 2: Grand Ballroom

ROUNDTABLE: The Future of Kidney Brain Health

Mitch Elkind; Peter McCaffrey; Jochen Reiser

Moderator: Harris Eyre

4:15–5:30 PM

GICC: Galleon Room

Poster Sessions & Networking

7:30–8:55 AM

GICC Level 1: West Foyer

Breakfast

Theme 5

Breaking Barriers for Successful Trial Recruitment & Execution

9:00–9:05 AM

GICC Level 2: Grand Ballroom

Introduction

Josh Tarnoff

9:05–9:15 AM

GICC Level 2: Grand Ballroom

Voice of the Patient

Jemila Alharazim

Moderator: Josh Tarnoff

9:15–9:25 AM

GICC Level 2: Grand Ballroom

GD Centers of Excellence

Tobias B. Huber; Ali Poyan Mehr

9:25–10:10 AM

GICC Level 2: Grand Ballroom

ROUNDTABLE: Voice of the Clinical Trial Village: Improving Recruitment & Execution (and Workgroup announcement)

Meg Jardine; Brittain Kopittke; Sreedhar Mandayam; Jennifer McKenzie; Kristin Nabors; Marina Vivarelli

Moderators: Barbara Gillespie; Josh Tarnoff

10:10–10:35 AM

GICC Level 2: Grand Ballroom

From Trial Challenges to Trial Solutions

Erika Allred; Sweta Sinha; Bill Smoyer

Moderator: Shikha Wadhwani

10:35–11:00 AM

GICC Level 2: Grand Ballroom Foyer

Coffee Break

11:00–11:45 AM

GICC Level 2: Grand Ballroom

Late Breaking Research

TBA

Moderators: Prabir Roy-Chaudhury; Sydney Tang

11:45 AM–12:30 PM

GICC Level 2: Grand Ballroom

ROUNDTABLE: Voice of Pharma’s C Suite: What Keeps Us Up At Night

Rob Brenner; Jula Inrig; Jiahua Li

Moderator: Uptal Patel

12:30–12:45 PM

GICC Level 2: Grand Ballroom

Awards & Closing

Tobias B. Huber

12:45–2:15 PM

GICC Level 1: West Foyer

Farewell Lunch

Boxed lunch options available.

Clinical Trials Summit Speaker List

Speakers A–H

Suceena Alexander
Christian Medical College Vellore

Jemila Alharazim
Patient

Sahir Ali
Modi Ventures

Erika Allred
Natera

Laura Barisoni
Duke University

Sean Barbour
The University of British Columbia

Jonathan Barratt
University of Leicester

Rob Brenner
Vera Therapeutics

Alice Brown
Purespring Therapeutics

Kirk Campbell
University of Pennsylvania

Nadia Chaudhri
CDER FDA Nephrologist

Alexander Duncan
Walden Biosciences

Mitch Elkind
American Heart Association, Columbia University

Harris Eyre
Rice University, UTMB

Alessia Fornoni
University of Miami

Daniel Gale
University College London

Barbara Gillespie
ISGD, University of North Carolina

Tom Greene
University of Utah Health

Vineet Gupta
University of Texas Medical Branch

Hiddo Heerspink
University Medical Center Groningen

Jonathan Hogan
Cabaletta Bio

Austin Hu
CDER FDA Nephrologist

Tobias B. Huber
ISGD, University Medical Center Hamburg-Eppendorf

Speakers I–P

Lesley Inker
Tufts University School of Medicine

Jula Inrig
Travere Therapeutics

Meg Jardine
The University of Sydney

Rekha Kambhampati
CDER FDA Nephrologist

Myda Khalid
Riley Hospital for Children, Indiana University School of Medicine

Brittan Kopittke
University of North Carolina

Rafael Kramann
Rheinisch-Westfälische Technische Hochschule, Aachen University

Matthias Kretzler
University of Michigan

Adeera Levin
University of British Columbia, Providence Health Care

Jiahua Li
Vertex Pharmaceuticals

Liz Lightstone
Imperial College London

Ana Malvar
University of Buenos Aires

Sreedhar Mandayam
UT MD Anderson Cancer Center

Laura Mariani
University of Michigan

Kedar Mate
Cornell, Qualified Health

Jennifer McKenzie
Boehringer Ingelheim

Alex Mercer
JAMCO Pharma Consulting

Kirtida Mistry
CDER FDA Nephrologist

Kristin Nabors
Johns Hopkins University

Patrick Nachman
University of Minnesota

Carla Nester
University of Iowa

Brendon Neuen
The George Institute for Global Health

Timothy Niewold
Hospital for Special Surgery

Louise Oni
University of Liverpool

Uptal Patel
Estuary Bio

Vlado Perkovic
University of New South Wales Sydney

Jule Pinter
University Medical Center Hamburg-Eppendorf

Ali Poyan Mehr
Kaiser Permanente Bernard J. Tyson School of Medicine

Speakers R–W

Heather Reich
University of Toronto

Jochen Reiser
University of Texas Medical Branch

Brad Rovin
The Ohio State University

Prabir Roy-Chaudhury
University of North Carolina

Eloise Salmon
University of Michigan

Sweta Sinha
iTrials

Abigail Smith
Northwestern University

William Smoyer
Nationwide Children’s Hospital

Sydney Tang
The University of Hong Kong

Anam Tariq
Former CBER FDA Nephrologist

Josh Tarnoff
NephCure

Aliza Thompson
CDER FDA Nephrologist

Nicola Tomas
University Medical Center Hamburg-Eppendorf

Michael Torres
CrossBridge Bio

Katherine Tuttle
University of Washington, Providence Medical Research Center

Priya Verghese
Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University

Marina Vivarelli
Bambino Gesù Children’s Hospital, IRCCS

Shikha Wadhwani
University of Texas Medical Branch

Thank you to our Sponsors

Special thanks to our Diamond and Platinum Sponsors for supporting the scholarship travel of 3 early career clinicians each.

Diamond

Qualified Health logo
Travere Therapeutics logo
Vertex

Platinum

Vera Therapeutics logo

Gold

Biogen
Bunkerhill Health
Otsuka

Silver

AstraZeneca
Boehringer Ingelheim
Jade Biosciences logo

Bronze

Avicenna Clínicas logo
Metis logo
NIPOKA logo